<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36708815</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6825</ISSN><JournalIssue CitedMedium="Internet"><Volume>151</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of allergy and clinical immunology</Title><ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Rhinovirus infection of the airway epithelium enhances mast cell immune responses via epithelial-derived interferons.</ArticleTitle><Pagination><StartPage>1484</StartPage><EndPage>1493</EndPage><MedlinePgn>1484-1493</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaci.2022.12.825</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0091-6749(23)00088-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Mast cells (MCs) within the airway epithelium in asthma are closely related to airway dysfunction, but cross talk between airway epithelial cells (AECs) and MCs in asthma remains incompletely understood. Human rhinovirus (RV) infections are key triggers for asthma progression, and AECs from individuals with asthma may have dysregulated antiviral responses.</AbstractText><AbstractText Label="OBJECTIVE">We utilized primary AECs in an ex&#xa0;vivo coculture model system to examine cross talk between AECs and MCs after epithelial rhinovirus infection.</AbstractText><AbstractText Label="METHODS">Primary AECs were obtained from 11 children with asthma and 10 healthy children, differentiated at air-liquid interface, and cultured in the presence of laboratory of allergic diseases 2 (LAD2) MCs. AECs were infected with rhinovirus serogroup A&#xa0;16 (RV16) for 48 hours. RNA isolated from both AECs and MCs underwent RNA sequencing. Direct effects of epithelial-derived interferons on LAD2 MCs were examined by real-time quantitative PCR.</AbstractText><AbstractText Label="RESULTS">MCs increased expression of proinflammatory and antiviral genes in AECs. AECs demonstrated a robust antiviral response after RV16 infection that resulted in significant changes in MC gene expression, including upregulation of genes involved in antiviral responses, leukocyte activation, and type 2 inflammation. Subsequent ex&#xa0;vivo modeling demonstrated that IFN-&#x3b2; induces MC type 2 gene expression. The effects of AEC donor phenotype were small relative to the effects of viral infection and the presence of MCs.</AbstractText><AbstractText Label="CONCLUSIONS">There is significant cross talk between AECs and&#xa0;MCs, which are present in the epithelium in asthma. Epithelial-derived interferons not only play a role in viral suppression but also further alter MC immune responses including specific type 2 genes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Ryan C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Seattle, Wash; Center for Lung Biology, University of Washington, Seattle, Wash. Electronic address: saxons05@uw.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Seattle, Wash; Center for Lung Biology, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altman</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Disease, Department of Medicine, Seattle, Wash; Immunology Program, Benaroya Research Institute, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrow</LastName><ForeName>Kaitlyn A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Sleep Medicine, Seattle Children's Hospital, Department of Pediatrics, Seattle, Wash; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dill-McFarland</LastName><ForeName>Kimberly A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Disease, Department of Medicine, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Seattle, Wash; Center for Lung Biology, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamerman</LastName><ForeName>Jessica A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Immunology Program, Benaroya Research Institute, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacy-Hulbert</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Immunology Program, Benaroya Research Institute, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piliponsky</LastName><ForeName>Adrian M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Steven F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Immunology Program, Benaroya Research Institute, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altemeier</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Seattle, Wash; Center for Lung Biology, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debley</LastName><ForeName>Jason S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Sleep Medicine, Seattle Children's Hospital, Department of Pediatrics, Seattle, Wash; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gharib</LastName><ForeName>Sina A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Seattle, Wash; Center for Lung Biology, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallstrand</LastName><ForeName>Teal S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Seattle, Wash; Center for Lung Biology, University of Washington, Seattle, Wash.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 AI130263</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI175089</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI163160</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI125378</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AI150991</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL153979</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32 HL159889</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol</MedlineTA><NlmUniqueID>1275002</NlmUniqueID><ISSNLinking>0091-6749</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C535755">Congenital disorder of glycosylation, type 2C</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008407" MajorTopicYN="N">Mast Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004848" MajorTopicYN="N">Epithelium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asthma</Keyword><Keyword MajorTopicYN="N">T2&#xa0;inflammation</Keyword><Keyword MajorTopicYN="N">airway epithelium</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">mast cell</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement>Conflict of Interest Disclosure Statement: Dr. Hamerman reports receiving consulting fees from aTyr Pharma. Dr. Altman reports receiving consulting fees from Regeneron. All other authors have no conflicts of interest or disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>28</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36708815</ArticleId><ArticleId IdType="mid">NIHMS1870117</ArticleId><ArticleId IdType="pmc">PMC10257743</ArticleId><ArticleId IdType="doi">10.1016/j.jaci.2022.12.825</ArticleId><ArticleId IdType="pii">S0091-6749(23)00088-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murphy RC, Pavord ID, Alam R, Altman MC. Management Strategies to Reduce Exacerbations in non-T2 Asthma. J Allergy Clin Immunol Pract. 2021;9(7):2588&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">34246435</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman MC, Lai Y, Nolin JD, Long S, Chen CC, Piliponsky AM, et al. Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling. J Clin Invest. 2019;129(11):4979&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6819127</ArticleId><ArticleId IdType="pubmed">31437129</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy RC, Hallstrand TS. Exploring the origin and regulatory role of mast cells in asthma. Curr Opin Allergy Clin Immunol. 2021;21(1):71&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10038756</ArticleId><ArticleId IdType="pubmed">33369571</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavala ML, Bertics PJ, Gern JE. Rhinoviruses, allergic inflammation, and asthma. Immunol Rev. 2011;242(1):69&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119863</ArticleId><ArticleId IdType="pubmed">21682739</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119(5):1105&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125611</ArticleId><ArticleId IdType="pubmed">17353039</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201(6):937&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213100</ArticleId><ArticleId IdType="pubmed">15781584</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol. 2009;123(6):1384&#x2013;90.e2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2744461</ArticleId><ArticleId IdType="pubmed">19428098</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 2010;3(1):69&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2884103</ArticleId><ArticleId IdType="pubmed">19710636</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes A, Macintyre J, Edwards MR, Del Rosario A, Haas J, Gielen V, et al. Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax. 2014;69(3):240&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24127021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014;190(12):1373&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4299647</ArticleId><ArticleId IdType="pubmed">25350863</ArticleId></ArticleIdList></Reference><Reference><Citation>Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008;105(36):13562&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2528869</ArticleId><ArticleId IdType="pubmed">18768794</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman MC, Reeves SR, Parker AR, Whalen E, Misura KM, Barrow KA, et al. Interferon response to respiratory syncytial virus by bronchial epithelium from children with asthma is inversely correlated with pulmonary function. J Allergy Clin Immunol. 2018;142(2):451&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5951761</ArticleId><ArticleId IdType="pubmed">29106997</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy RC, Lai Y, Barrow KA, Hamerman JA, Lacy-Hulbert A, Piliponsky AM, et al. Effects of Asthma and Human Rhinovirus A16 on the Expression of SARS-CoV-2 Entry Factors in Human Airway Epithelium. Am J Respir Cell Mol Biol. 2020;63(6):859&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7790138</ArticleId><ArticleId IdType="pubmed">32946274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Guisa JM, Powers C, File D, Cochrane E, Jimenez N, Debley JS. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J Allergy Clin Immunol. 2012;129(4):990&#x2013;7.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3604976</ArticleId><ArticleId IdType="pubmed">22227417</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47(W1):W199&#x2013;W205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602449</ArticleId><ArticleId IdType="pubmed">31114916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer A, Green J, Pollard J, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30(4):523&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderwall ER, Barrow KA, Rich LM, Read DF, Trapnell C, Okoloko O, et al. Airway epithelial interferon response to SARS-CoV-2 is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication. bioRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9048621</ArticleId><ArticleId IdType="pubmed">35484173</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F, Wachi S, Thai P, Loukoianov A, Tan KH, Forteza RM, et al. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. J Allergy Clin Immunol. 2008;121(6):1415&#x2013;21, 21.e1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631388</ArticleId><ArticleId IdType="pubmed">18539194</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb Sharif-Askari F, Saheb Sharif-Askari N, Goel S, Mahboub B, Ansari AW, Temsah MH, et al. Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity. ERJ Open Res. 2021;7(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8311130</ArticleId><ArticleId IdType="pubmed">34322544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermers MJ, Janssen R, Onland-Moret NC, Hodemaekers HM, Rovers MM, Houben ML, et al. IL10 family member genes IL19 and IL20 are associated with recurrent wheeze after respiratory syncytial virus bronchiolitis. Pediatr Res. 2011;70(5):518&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">21814157</ArticleId></ArticleIdList></Reference><Reference><Citation>Azuma YT, Nishiyama K. Interleukin-19 enhances cytokine production induced by lipopolysaccharide and inhibits cytokine production induced by polyI:C in BALB/c mice. J Vet Med Sci. 2020;82(7):891&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399314</ArticleId><ArticleId IdType="pubmed">32378521</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas MA, Buelow BJ, Nevins AM, Jones SE, Peterson FC, Gundry RL, et al. Structure-function analysis of CCL28 in the development of post-viral asthma. J Biol Chem. 2015;290(7):4528&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4326855</ArticleId><ArticleId IdType="pubmed">25556652</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4(7):574&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5007068</ArticleId><ArticleId IdType="pubmed">27283230</ArticleId></ArticleIdList></Reference><Reference><Citation>Dienz O, Rincon M. The effects of IL-6 on CD4 T cell responses. Clin Immunol. 2009;130(1):27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2660866</ArticleId><ArticleId IdType="pubmed">18845487</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgari S, Schlapbach LJ, Anchisi S, Hammer C, Bartha I, Junier T, et al. Severe viral respiratory infections in children with. Proc Natl Acad Sci U S A. 2017;114(31):8342&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5547624</ArticleId><ArticleId IdType="pubmed">28716935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho AT, Sharma S, Qiu W, Gaedigk R, Klanderman B, Niu S, et al. Vitamin D related genes in lung development and asthma pathogenesis. BMC Med Genomics. 2013;6:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4228235</ArticleId><ArticleId IdType="pubmed">24188128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa T, Okazawa T, Uga H, Kurata H, Mori A. Serum CXCL9 as a potential marker of T1 inflammation in the context of eosinophilic asthma. Allergy. 2019;74(12):2515&#x2013;2518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6972734</ArticleId><ArticleId IdType="pubmed">31125435</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H, Hao Y, Li W, Yang W, Gao P. IL-36 cytokines: their roles in asthma and potential as a therapeutic. Front Immunol. 2022. Jul 12;13:921275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9314646</ArticleId><ArticleId IdType="pubmed">35903102</ArticleId></ArticleIdList></Reference><Reference><Citation>Akoto C, Davies DE, Swindle EJ. Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations. Clin Exp Allergy. 2017;47(3):351&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5396281</ArticleId><ArticleId IdType="pubmed">28008678</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Y, Huang W, Liang J, Guo J, Ji J, Yao Y, et al. IL4I1 Is a Novel Regulator of M2 Macrophage Polarization That Can Inhibit T Cell Activation via L-Tryptophan and Arginine Depletion and IL-10 Production. PLoS One. 2015;10(11):e0142979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658051</ArticleId><ArticleId IdType="pubmed">26599209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CK, Ho CY, Ko FW, Chan CH, Ho AS, Hui DS, et al. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol. 2001;125(2):177&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1906135</ArticleId><ArticleId IdType="pubmed">11529906</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H, Miyazaki N, Oashi K, Teramoto S, Shiratori M, Hashimoto M, et al. IL-18 might reflect disease activity in mild and moderate asthma exacerbation. J Allergy Clin Immunol. 2001;107(2):331&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11174201</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada M, Obara K, Hirota T, Yoshimoto T, Hitomi Y, Sakashita M, et al. A functional polymorphism in IL-18 is associated with severity of bronchial asthma. Am J Respir Crit Care Med. 2009;180(11):1048&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">19745201</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaoka H, Gauvreau GM, Watson RM, Smith SG, Dua B, Baatjes AJ, et al. Interleukin-18 and interleukin-18 receptor-&#x3b1; expression in allergic asthma. Eur Respir J. 2011;38(4):981&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">21965503</ArticleId></ArticleIdList></Reference><Reference><Citation>Higa S, Hirano T, Mayumi M, Hiraoka M, Ohshima Y, Nambu M, et al. Association between interleukin-18 gene polymorphism 105A/C and asthma. Clin Exp Allergy. 2003;33(8):1097&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">12911784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CC, Lin WY, Wan L, Tsai Y, Tsai CH, Huang CM, et al. Association of interleukin-18 gene polymorphism with asthma in Chinese patients. J Clin Lab Anal. 2008;22(1):39&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6649026</ArticleId><ArticleId IdType="pubmed">18200581</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng D, Hao Y, Zhou W, Ma Y. The relationship between interleukin-18 polymorphisms and allergic disease: a meta-analysis. Biomed Res Int. 2014;2014:290687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066680</ArticleId><ArticleId IdType="pubmed">24995282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">11244043</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi K Unique Action of Interleukin-18 on T Cells and Other Immune Cells. Front Immunol. 2018;9:763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5920033</ArticleId><ArticleId IdType="pubmed">29731751</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurak LM, Xi Y, Landgraf M, Carroll ML, Murray L, Upham JW. Interleukin 33 Selectively Augments Rhinovirus-Induced Type 2 Immune Responses in Asthmatic but not Healthy People. Front Immunol. 2018;9:1895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6108046</ArticleId><ArticleId IdType="pubmed">30174671</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JS, Portales-Cervantes L, Leong E. Mast Cell Responses to Viruses and Pathogen Products. Int J Mol Sci. 2019;20(17).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747121</ArticleId><ArticleId IdType="pubmed">31480219</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K, Taguchi F. Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus. Virology. 2009;386(1):88&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">19195674</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Tan J, Liu J, Feng H, Pan D. Altered mast cell activity in response to rhinovirus infection provides novel insight into asthma. J Asthma. 2020;57(5):459&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">30882256</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldford SA, Salsman SP, Portales-Cervantes L, Alyazidi R, Anderson R, Haidl ID, et al. Interferon &#x3b1;2 and interferon &#x3b3; induce the degranulation independent production of VEGF-A and IL-1 receptor antagonist and other mediators from human mast cells. Immun Inflamm Dis. 2018;6(1):176&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818443</ArticleId><ArticleId IdType="pubmed">29235261</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Ren G, Gong Y, Dong S, Yin Y, Zhang L. Bronchial epithelial cells release IL-6, CXCL1 and CXCL8 upon mast cell interaction. Cytokine. 2011;56(3):823&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">22030312</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes DA, Yeh JH, Yan D, Xu M, Chan AC. Dusp5 negatively regulates IL-33-mediated eosinophil survival and function. EMBO J. 2015;34(2):218&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4337062</ArticleId><ArticleId IdType="pubmed">25398911</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramu S, Akbarshahi H, Mogren S, Berlin F, Cerps S, Menzel M, et al. Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses. BMC Immunol. 2021;22(1):35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170739</ArticleId><ArticleId IdType="pubmed">34078278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicic A, Sutanto EN, Stevens PT, Knight DA, Stick SM. Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. Am J Respir Crit Care Med. 2006;174(10):1110&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16908868</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicic A, Hallstrand TS, Sutanto EN, Stevens PT, Kobor MS, Taplin C, et al. Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. Am J Respir Crit Care Med. 2010;181(9):889&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2862303</ArticleId><ArticleId IdType="pubmed">20110557</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves SR, Barrow KA, White MP, Rich LM, Naushab M, Debley JS. Stability of gene expression by primary bronchial epithelial cells over increasing passage number. BMC pulmonary medicine. 2018;18(1):91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5975426</ArticleId><ArticleId IdType="pubmed">29843677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Edelman JD, Gharib SA. Comparative evaluation of miRNA expression between in vitro and in vivo airway epithelium demonstrates widespread differences. Am J Pathol. 2013;183(5):1405&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814685</ArticleId><ArticleId IdType="pubmed">24001474</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel DA, You Y, Huang G, Byers DE, Kim HJ, Agapov E, et al. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. J Allergy Clin Immunol. 2014;134(6):1402&#x2013;12.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4261010</ArticleId><ArticleId IdType="pubmed">25216987</ArticleId></ArticleIdList></Reference><Reference><Citation>Veerati PC, Troy NM, Reid AT, Li NF, Nichol KS, Kaur P, et al. Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD. Front Immunol. 2020;11:974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243842</ArticleId><ArticleId IdType="pubmed">32499788</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>